Q&A

nTIDE November 2022 Jobs Report: People with disabilities continue to outperform people without disabilities in labor market

Retrieved on: 
Friday, December 2, 2022

EAST HANOVER, N.J., Dec. 2, 2022 /PRNewswire/ -- Job numbers rose again for people with disabilities, in contrast to people without disabilities, according to today's National Trends in Disability Employment – Monthly Update (nTIDE), issued by Kessler Foundation and the University of New Hampshire's Institute on Disability (UNH-IOD). People with disabilities continued to show strength in the labor market in November, as evidenced by the substantial rise in their employment-to-population ratio.

Key Points: 
  • People with disabilities continued to show strength in the labor market in November, as evidenced by the substantial rise in their employment-to-population ratio.
  • "Similar to last month, the employment-to-population ratio for people with disabilities increased and remains above historic highs.
  • Our new survey compares the workplaces of 2017 and 2022, revealing gains in recruiting, hiring, accommodating, and retaining employees with disabilities.
  • Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities.

Genprex to Present at Upcoming December Investor Conference

Retrieved on: 
Friday, December 2, 2022

AUSTIN, Texas , Dec. 2, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Executive Vice President, General Counsel and Chief Strategy Officer, Catherine Vaczy, will be providing an overview of the Company's gene therapies for cancer and diabetes at the following investor conference in December 2022.

Key Points: 
  • Ms. Vaczy will be available for Q&A following the presentation and for in-person one-on-one meetings with investors at the RHK Disruptive Growth Conference.
  • Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.
  • Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
  • You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all.

good natured to Host Investor Webcast on December 8th, 2022

Retrieved on: 
Friday, December 2, 2022

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2022) - good natured Products Inc. (TSXV: GDNP) (OTCQX: GDNPF) (the "Company" or "good natured"), a North American leader in -based products, announced today that it will host a webcast investor presentation on Thursday, December 8th, 2022 at 2:00 PM Eastern / 11:00 AM Pacific time.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - December 2, 2022) - good natured Products Inc. (TSXV: GDNP) (OTCQX: GDNPF) (the "Company" or "good natured"), a North American leader in -based products, announced today that it will host a webcast investor presentation on Thursday, December 8th, 2022 at 2:00 PM Eastern / 11:00 AM Pacific time.
  • During the webcast, Paul Antoniadis, Chief Executive Officer of good natured, will provide a presentation through a PowerPoint discussion that will cover key areas of the Company's business.
  • After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.
  • good natured offers over 400 products and services through wholesale, direct to business, and retail channels.

Iris Energy to Provide Strategic Update and Host Conference Call on December 6, 2022

Retrieved on: 
Friday, December 2, 2022

Please note, participants joining the conference call via the phone dial-in option will receive their dial-in number, passcode and PIN following registration using the link above.

Key Points: 
  • Please note, participants joining the conference call via the phone dial-in option will receive their dial-in number, passcode and PIN following registration using the link above.
  • It would be appreciated if all callers could dial in approximately 5 minutes prior to the scheduled start time.
  • There will be a Q&A session after the Company has provided its strategic update.
  • Iris Energy is a sustainable Bitcoin mining company that supports the decarbonization of energy markets and the global Bitcoin network.

Cerence to Present at the Raymond James Technology Investors Conference

Retrieved on: 
Thursday, December 1, 2022

BURLINGTON, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today that it will be presenting at the Raymond James Technology Investors Conference in New York City on Tuesday, December 6, 2022 at 1:40 p.m. Eastern Time.

Key Points: 
  • BURLINGTON, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, announced today that it will be presenting at the Raymond James Technology Investors Conference in New York City on Tuesday, December 6, 2022 at 1:40 p.m. Eastern Time.
  • The format for the conference will be a presentation followed by Q&A featuring Tom Beaudoin, Cerence EVP, CFO.
  • Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world.
  • Cerences track record is built on more than 20 years of knowledge and more than 450 million cars shipped with Cerence technology.

Brenmiller Energy to Host Investor Update Webinar on December 6th

Retrieved on: 
Thursday, December 1, 2022

Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that it will host a webinar on Tuesday, December 6, 2022 at 9:00 a.m. Eastern Standard Time / 4:00 p.m. Israel Standard Time.

Key Points: 
  • Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that it will host a webinar on Tuesday, December 6, 2022 at 9:00 a.m. Eastern Standard Time / 4:00 p.m. Israel Standard Time.
  • During the webinar, Nir Brenmiller, Chief Operating Officer, and Ofir Zimmerman, CPA, Chief Financial Officer will review the Companys current activity and provide an operational update, followed by a question-and-answer session.
  • To register for the presentation, please follow this Zoom link: https://us02web.zoom.us/webinar/register/WN_Af5uYB8-RP65Ai8qvKY3xw
    Participants are invited to submit questions via the registration page or during the webinar via the Q&A function.
  • Brenmiller Energy delivers scalable thermal energy storage solutions and services that allow customers to cost-effectively decarbonize their operations.

American Hair Research Society Hosts Hybrid Alopecia Areata Summit "New Pathways, New Treatments", December 10-11, 2022, in New York City

Retrieved on: 
Thursday, December 1, 2022

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- 

Key Points: 
  • WHO: Alopecia Areata Summit "New Pathways, New Treatments" organized by the American Hair Research Society; Co-Chaired by Angela M. Christiano, PhD, Columbia University; Wilma F. Bergfeld, MD, Cleveland Clinic; Maria Hordinsky, MD, University of Minnesota; and Antonella Tosti, MD, University of Miami.
  • Attendees may use their leisure time to enjoy New York City decked out for the holidays.
  • Keynote on "Cytokines, Jakinibs and Autoimmune Diseases," John J. O'Shea, MD, NIH/ NIAMS Scientific Director
    Keynote on "Is JAK All There is?
  • WHY: The goal of the Alopecia Areata Summit is to provide scientific and clinical education that can be immediately incorporated into clinical practice to improve outcomes for patients with alopecia areata.

Executive CARLOS BUSCH accepted into Forbes Business Council

Retrieved on: 
Thursday, December 1, 2022

SAO PAULO, Dec. 1, 2022 /PRNewswire-PRWeb/ -- Forbes Business Council Is an Invitation-Only Community for Successful Business Owners and Leaders

Key Points: 
  • CARLOS BUSCH, former Salesforce Latam VP and top reference in sales and customer experience in Latin America, has been accepted into the Forbes Business Council.
  • CARLOS BUSCH, former Salesforce Latam VP and top reference in sales and customer experience in Latin America, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.
  • "We are honored to welcome Carlos Busch into the community," said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council.
  • As an accepted member of the Council, Carlos Busch has access to a variety of exclusive opportunities designed to help him reach peak professional influence.

Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day

Retrieved on: 
Thursday, December 1, 2022

To access the live webcast and presentation slides, visit our web site at www.pfizer.com/investors .

Key Points: 
  • To access the live webcast and presentation slides, visit our web site at www.pfizer.com/investors .
  • Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today.
  • The forward-looking statements in the webcast speak only as of the original date of the webcast.
  • Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

SES AI Corporation To Host Battery World 2022 Event

Retrieved on: 
Thursday, December 1, 2022

SES AI Corporation (NYSE: SES) (SES, SES AI or the Company), a global leader in the development and manufacturing of high-performance lithium-metal (Li-Metal) rechargeable batteries for electric vehicles (EVs) and other applications, headquartered in Boston, USA and with facilities in Shanghai and South Korea, today announced the agenda Battery World 2022.

Key Points: 
  • SES AI Corporation (NYSE: SES) (SES, SES AI or the Company), a global leader in the development and manufacturing of high-performance lithium-metal (Li-Metal) rechargeable batteries for electric vehicles (EVs) and other applications, headquartered in Boston, USA and with facilities in Shanghai and South Korea, today announced the agenda Battery World 2022.
  • View the full release here: https://www.businesswire.com/news/home/20221201005593/en/
    The 2nd annual Battery World 2022 will held on December 14th, 2022 - 11:00AM EST.
  • A replay of Battery World 2022 will be continuously available on www.ses.ai after the event takes place.
  • Following Battery World U.S. on December 13, SES AI will hold similar events in both South Korea and China.